World News: 07:14 GMT Wednesday 13th February 2013. [Stock Market via SPi World News]
LONDON (Reuters) - Reckitt Benckiser beat full-year earnings expectations as the maker of Strepsils and Mucinex benefited from an unusually heavy U.S. cold and flu season in the final quarter. Full-year adjusted earnings per share was 264.4 pence, compared to Thomson Reuters I/B/E/S estimates of 246.8 pence and a company-supplied forecast of 249 pence. An early and unusually intense flu season in North America has pushed up business for hospitals, pharmacies and the makers of tissues and cold remedies. (Reporting by Rosalba O'Brien; Editing by Paul Sandle)
Read More: http://news.yahoo.com/reckitt-benckiser-beats-earnings-forecasts-071435313--sector.html
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2017. [Admin Only]
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.